IFN‐α/β enhances BCR‐dependent B cell responses
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Type I interferon (IFN-I) is constitutively produced in the bone marrow (BM), and induced at sites of inflammation and following infection by viruses or microorganisms. We have previously shown that IFN-I regulates the generation and selection of normal B cell populations in the BM. In the present work, we assess the effects of IFN-I on mature B cell function by monitoring the responses of IFN-alpha/beta-treated murine splenic B cells to apoptotic, mitogenic and activating stimuli. A similar analysis is performed on BM mature B cells obtained from wild-type or IFN-I receptor-deficient mice. IFN-alpha/beta is shown to induce B cells to a state of partial activation characterized by the up-regulation of CD69, CD86 and CD25 molecules in the absence of either proliferation or terminal differentiation. B cells treated with IFN-alpha/beta show an increased survival and resistance to Fas-mediated apoptosis. IFN-alpha/beta also enhances B cell responses to BCR ligation such as calcium fluxes, IgM internalization, induction of activation markers and proliferation. These results indicate that in addition to its inhibitory effect on viral replication and T cell apoptosis, IFN-alpha/beta plays an essential role during an inflammatory response by lowering the threshold for B cell induction, thereby promoting fast and polyclonal antibody responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Lam, K.-P., Kühn, R., & Rajewsky, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80373-6 · Cited by 1,108
Induction of Bystander T Cell Proliferation by Viruses and Type I Interferon in Vivo
Tough, D. F., Borrow, P., & Sprent, J. (1996) · Science · doi:10.1126/science.272.5270.1947 · Cited by 1,077
Type I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 759
Samuel, C. E. (1991) · Virology · doi:10.1016/0042-6822(91)90112-o · Cited by 602
Activation and function of natural killer cell responses during viral infections
Biron, C. A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80155-0 · Cited by 420
Side effects of α interferon in chronic hepatitis C
Dusheiko, G. (1997) · Hepatology · doi:10.1002/hep.510260720 · Cited by 397
Tedder, T. F., Inaoki, M., & Sato, S. (1997) · Immunity · doi:10.1016/s1074-7613(00)80418-5 · Cited by 383
Cited by
Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001180 · Cited by 1,303
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185
Multiple early factors anticipate post-acute COVID-19 sequelae
Su, Y., Yuan, D., Chen, D. G., Ng, R. H., Wang, K., Choi, J., Li, S., Hong, S., Zhang, R., Xie, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.014 · Cited by 1,156
Antitumour actions of interferons: implications for cancer therapy
Parker, B. S., Rautela, J., & Hertzog, P. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.14 · Cited by 907
Survival of Resting Mature B Lymphocytes Depends on BCR Signaling via the Igα/β Heterodimer
Kraus, M., Alimzhanov, M. B., Rajewsky, N., & Rajewsky, K. (2004) · Cell · doi:10.1016/j.cell.2004.05.014 · Cited by 572
Lövgren, T., Eloranta, M., Båve, U., Alm, G. V., & Rönnblom, L. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20254 · Cited by 552
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice
Santiago-Raber, M.-L., Baccala, R., Haraldsson, K. M., Choubey, D., Stewart, T. A., Kono, D. H., & Theofilopoulos, A. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021996 · Cited by 509
B cells responses and cytokine production are regulated by their immune microenvironment
Vazquez, M. I., Catalan-Dibene, J., & Zlotnik, A. (2015) · Cytokine · doi:10.1016/j.cyto.2015.02.007 · Cited by 421
Le Bon, A., Thompson, C., Kamphuis, E., Durand, V., Rossmann, C., Kalinke, U., & Tough, D. F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2074 · Cited by 361
The type I interferon system in systemic lupus erythematosus
Rönnblom, L., Eloranta, M., & Alm, G. V. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21571 · Cited by 341
Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia
Kamphuis, E., Junt, T., Waibler, Z., Forster, R., & Kalinke, U. (2006) · Blood · doi:10.1182/blood-2006-06-027599 · Cited by 306
Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S., & Endres, S. (2003) · European Journal of Immunology · doi:10.1002/eji.200323813 · Cited by 296
Burke, J. R., Cheng, L., Gillooly, K. M., Strnad, J., Zupa-Fernandez, A., Catlett, I. M., Zhang, Y., Heimrich, E. M., McIntyre, K. W., Cunningham, M. D., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1736 · Cited by 289
B cells as therapeutic targets in SLE
Sanz, I., & Lee, F. E.-H. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.68 · Cited by 261
Development and selection of marginal zone B cells
Lopes‐Carvalho, T., & Kearney, J. F. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0112.x · Cited by 253
Interferons as pathogenic effectors in autoimmunity
Baccala, R., Kono, D. H., & Theofilopoulos, A. N. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00252.x · Cited by 199
Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice
Braun, D. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(02)00109-9 · Cited by 182
Self-citationMinnaert, A.-K., Vanluchene, H., Verbeke, R., Lentacker, I., De Smedt, S. C., Raemdonck, K., Sanders, N. N., & Remaut, K. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113900 · Cited by 157
Regulation of autoreactive B cell responses to endogenous TLR ligands
Avalos, A. M., Busconi, L., & Marshak-Rothstein, A. (2010) · Autoimmunity · doi:10.3109/08916930903374618 · Cited by 114
Role of dendritic cells in innate and adaptive immune response in human aging
Gupta, S. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2013.12.009 · Cited by 80
Wegenka, U. M., Dikopoulos, N., Reimann, J., Adler, G., & Wahl, C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.08.009 · Cited by 30
Metadata
- Authors
- Braun, D., Caramalho, I., & Demengeot, J.
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-04
- Volume
- 14
- Issue
- 4
- Pages
- 411-419
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2100081088
- Cited by
- 268
- References
- 31
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.